Atropine sulfate monohydrate
Molecular Weight(MW): 694.83
Atropine sulfate monohydrate is a competitive antagonist for the muscarinic acetylcholine receptor, used to decrease the production of saliva and secretions of the airway prior to surgery.
Purity & Quality Control
Choose Selective AChR Inhibitors
|Description||Atropine sulfate monohydrate is a competitive antagonist for the muscarinic acetylcholine receptor, used to decrease the production of saliva and secretions of the airway prior to surgery.|
Atropine increases the release of the neurotransmitter dopamine into the superfusate in vitro at 100-500 mM and into the vitreous in vivo at 250 mg. Atropine induces spreading depression (SD) in the in vitro preparation. Atropine reduces the ERG b- and d-wave, leads to damped oscillations of RPE potentials, and reverses the ERG c-wave. Atropine suppresses myopia only at doses at which severe nonspecific side effects are observed in the retina. 
|In vivo||Atropine (1.0 mg/kg, i.p.), but not methylatropine (1.0 mg/kg, i.p.), prevents the enhancement of retention induced by both doses of the anticholinesterase when given immediately after training in mice.  Atropine administration effectively prevents bradycardia and second-degree heart block but induces pulsus alternans and hypertension in dogs.  Atropine has no effect on handling-induced acetylcholine output in the presence of 10 nM neostigmine, but causes greater and longer increases in the presence of 100 nM and 1000 nM neostigmine in rats.  Atropine not only blocks the rapid eye movement (REM) sleep increases induced by CGS but it also tends to decrease REM sleep compared to atropine preceding saline in rats.  Atropine decreases the time to exhaustion by 67% in intact rats and by 96.2% in adrenodemedullated (ADM) and also reduces the exercise-induced pituitary prolactin (PRL) release in both intact (50%) and ADM rats (90%). |
-  Schwahn HN, et al. Vis Neurosci,?000, 17(2), 165-176.
-  Boccia MM, et al. Neurosci Lett,?003, 345(2), 97-100.
-  Ko JC, et al. J Am Vet Med Assoc,?001, 218(1), 52-58.
|In vitro||DMSO||139 mg/mL (200.04 mM)|
|Water||139 mg/mL (200.04 mM)|
|Ethanol||139 mg/mL (200.04 mM)|
* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.
Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:
Mass (mg) = Concentration (mM) × Volume (mL) × Molecular Weight (g/mol)
*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).
Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )
* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).
Molecular Weight Calculator
Enter the chemical formula of a compound to calculate its molar mass and elemental composition:
Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2
Instructions to calculate molar mass (molecular weight) of a chemical compound:
To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.
Definitions of molecular mass, molecular weight, molar mass and molar weight:
Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.
Clinical Trial Information
|NCT Number||Recruitment||interventions||Conditions||Sponsor/Collaborators||Start Date||Phases|
|NCT04083768||Not yet recruiting||Device: 15° and 30° wedge sponges||Elective Cesarean Section|Spinal Anesthesia||Xuzhou Medical University||October 1 2019||Not Applicable|
|NCT04045951||Recruiting||Other: Myopia prediction algorithm||Myopia||Sun Yat-sen University||August 3 2019||Not Applicable|
|NCT04044755||Recruiting||Other: Myopia prediction algorithm||Refractive Errors||Sun Yat-sen University||August 3 2019||Not Applicable|
|NCT04005014||Not yet recruiting||Other: Myopia prediction algorithm||Eye--Refractive Errors||Sun Yat-sen University||July 8 2019||Not Applicable|
|NCT03854812||Recruiting||Drug: Magnesium Sulphate|Drug: Fentanyl|Drug: Propofol||Monitored Anesthesia Care||Kasr El Aini Hospital||March 1 2019||Phase 2|
Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.